Who to treat/who not to treat: Left heart disease

I. Lang (Wien, Austria)

Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Number: 16
Disease area: Pulmonary vascular diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Lang (Wien, Austria). Who to treat/who not to treat: Left heart disease. ERS Skills course - Pulmonary hypertension and pulmonary vascular disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Who to treat/who not to treat: L heart disease
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012



Right heart failure
Source: Eur Respir Monogr 2016; 74: 32-47
Year: 2016


Pulmonary hypertension in left heart disease
Source: Eur Respir Rev 2012 21: 338-346
Year: 2012



Right and left ventricular dysfunction in patients with COPD and heart failure
Source: Eur Respir J 2007; 30: Suppl. 51, 706s
Year: 2007

Pulmonary hypertension associated with left heart disease
Source: Eur Respir Mon 2012; 57: 119-137
Year: 2012


Right heart failure in pulmonary hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014



How to define pulmonary hypertension due to left heart disease
Source: Eur Respir J 2016; 48: 553-555
Year: 2016


Pulmonary hypertension due to left heart disease
Source: Eur Respir J, 53 (1) 1801897; 10.1183/13993003.01897-2018
Year: 2019



Right heart imaging and failure in pulmonary hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017

Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis
Source: Eur Respir J, 51 (4) 1702427; 10.1183/13993003.02427-2017
Year: 2018



Left and right ventricular function in patients with end-stage idiopathic pulmonary fibrosis. Which ventricle is most affected?
Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems
Year: 2009

Under pressure: pulmonary hypertension associated with left heart disease
Source: Eur Respir Rev 2015; 24: 665-673
Year: 2015



Keeping the kidney and heart in balance: management of end-stage right heart failure
Source: Virtual Congress 2020 – Breathing disorders and cardiovascular diseases
Year: 2020


Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart
Source: Eur Respir Rev 2009; 19: 72-82
Year: 2010



Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes
Source: Eur Respir J, 53 (3) 1802393; 10.1183/13993003.02393-2018
Year: 2019



Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes
Source: Eur Respir J, 53 (3) 1801894; 10.1183/13993003.01894-2018
Year: 2019



Left atrial enlargement is not rare in PAH- RA/LA ratio is significantly lower in PH due to left heart disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Beta-blockers in pulmonary arterial hypertension: evolving concepts of right heart failure
Source: Eur Respir J 2015; 46: 619-621
Year: 2015